Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

BMS-184476 and BMS-188797 covered at ACS/AACR meetings; BMS reveals structures

April 11, 2000

New antitumor tetrocarcin derivatives in early development at Japanese lab

April 11, 2000

Formamides from Glaxo Wellcome with potential as antitumor therapeutics

April 11, 2000

Progenics and Cytogen present preclinical progress on PSMA technology

April 11, 2000

Highly potent, non-thiol-containing FTase inhibitor characterized by BMS at AACR meeting

April 10, 2000

Abbott designs macrolide LHRH antagonists

April 10, 2000

Hybridon presents preclinical results with MDM2 antisense compound at AACR

April 10, 2000

Nonsecosteroidal, nonhypercalcemic VDR agonist with antitumor activity designed at Ligand

April 7, 2000

Positive preclinical data obtained for naked DNA prostate cancer vaccine

April 7, 2000

NewBiotics completes private placement and prepares to advance study of lead product

April 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...